Do your diabetes sensors work when oxygen is low? new study finds out
NCT ID NCT05144802
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study checked how well two continuous glucose monitors (Dexcom G6 and FreeStyle Libre) work when oxygen levels are low. Thirty people with type 1 or type 2 diabetes took part. Researchers compared sensor readings to blood tests during controlled low-oxygen conditions to see if the sensors stayed accurate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
May 2022
- Finished
-
Jan 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: all population * No history of respiratory diseases (childhood asthma, respiratory allergies, exercise-induced asthma or dyspnea) * Willing to participate and able to sign an informed consent form (ICF) * Being affiliated with the French Social Security Inclusion Criteria:Patients with diabetes * type 1 diabetes mellitus or type 2 diabetes mellitus (ADA definition) * Age : 18 to 75 years * stable diabetes treatment for more than 3 months * no diabetic retinopathy * no diabetic neuropathy * no cardiovascular diseases * no contra-indication for coronary computed tomography angiography or myocardial perfusion scintigraphy. Inclusion Criteria: Healthy volunteers * Age : 18 ; 40 years * No diabetes * No persistant drug use \> 3 months except contraception * Body mass index : \[18,5 - 29,9\] kg/m2 Non-inclusion criteria : all population * Active smokers * Pregnant or breastfeeding women, women of childbearing age without effective contraception * Known allergies to the patch. * Skin lesions at the sensor site that may interfere with sensor placement or accuracy * Major cardiovascular complications within the past 3 months * Decompensated congestive heart failure * Chronic respiratory failure * Chronic renal failure * Resting ambient air O2 saturation ≤95%. * Treatment with systemic corticosteroids * Severe hypertension (≥180 mmHg systolic pressure or ≥ 100 mmHg diastolic pressure) * Any concomitant disease or condition that the investigator believes may compromise patient safety or affect the conduct of the study * Anemia (Hb\<12g/dl) * History of severe mountain sickness * Concurrent participation in another clinical research study, * Persons benefiting from enhanced protection Non-inclusion criteria: Patients with diabetes * Absolute contraindications to physical activity (HAS definitin) : * Pulmonary arterial hypertension (\> 60 mm Hg) * Presence of intra-cardiac thrombus * Acute pericardial effusion * Severe obstructive cardiomyopathy * Symptomatic aortic stenosis * Recent thrombophlebitis with or without pulmonary embolism
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 1 diabetes mellitus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU
Poitiers, 86000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heartbeat test aims to catch hidden nerve damage in diabetes
- Gene therapy aims to free type 1 diabetics from insulin shots
- Can Home-Delivered meals help control diabetes?
- Muscle-Injected gene therapy aims to help type 1 diabetes control blood sugar
- New pill takes aim at stubborn blood sugar
- Gene therapy shots aim to save legs from amputation in diabetes